You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Respiratory Syncytial Virus Infections

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus-bronchiolitis Trial in

Recruiting
  • Respiratory Syncytial Virus Infections
  • +2 more
    • Hanover, Lower Saxony, Germany
    • +1 more
    Jun 7, 2021

    Covid19, RSV Infection, Influenza Type A Trial in United Kingdom (Group A (Sample Collection), Group B (Sample Collection),

    Recruiting
    • Covid19
    • +3 more
    • Group A (Sample Collection)
    • +2 more
    • Cambridge, United Kingdom
    • +5 more
    Jun 6, 2022

    Respiratory Syncytial Virus Infections Trial in United States (Saline Placebo (0.5mL injection), RSV F vaccine (0.5mL

    Completed
    • Respiratory Syncytial Virus Infections
    • Saline Placebo (0.5mL injection)
    • RSV F vaccine (0.5mL injection)
    • Nampa, Idaho
    • +6 more
    May 25, 2022

    Respiratory Syncytial Virus Infection Trial in Puerto Rico, United States (RSV mRNA LNP CL-0059 Low dose, RSV mRNA LNP CL-0137

    Recruiting
    • Respiratory Syncytial Virus Infection
    • RSV mRNA LNP CL-0059 Low dose
    • +6 more
    • Hollywood, Florida
    • +4 more
    Jan 17, 2023

    Respiratory Syncytial Virus Prophylaxis Trial (Motavizumab, Placebo)

    Completed
    Has Results
    • Respiratory Syncytial Virus Prophylaxis
    • Motavizumab
    • Placebo
    • (no location specified)
    Sep 10, 2021

    RSV Infection Trial in Lenexa (EDP-323, Placebo)

    Recruiting
    • RSV Infection
    • Lenexa, Kansas
      ICON, plc.
    Oct 17, 2022

    Respiratory Syncytial Virus Infections Trial in United States (RSV LID cp ?M2-2 Vaccine, Placebo)

    Terminated
    Has Results
    • Respiratory Syncytial Virus Infections
    • RSV LID cp ΔM2-2 Vaccine
    • Placebo
    • Los Angeles, California
    • +4 more
    Nov 4, 2021

    Respiratory Syncytial Virus (RSV), Respiratory Viral Infection, Acute Disease Trial in Izumo, Kyoto, Nara

    Not yet recruiting
    • Respiratory Syncytial Virus (RSV)
    • +2 more
      • Izumo, Shimane, Japan
      • +2 more
      Jun 13, 2023

      Respiratory Syncytial Virus Infections Trial in London (RSVPreF, Placebo)

      Completed
      • Respiratory Syncytial Virus Infections
      • RSVPreF
      • Placebo
      • London, United Kingdom
        Golam Kabir
      Sep 1, 2021

      RSV Infection Trial in Baltimore (RSV 6120/?NS2/1030s, Placebo)

      Completed
      • RSV Infection
      • RSV 6120/∆NS2/1030s
      • Placebo
      • Baltimore, Maryland
        Center for Immunization Research, Johns Hopkins Bloomberg School
      Jan 19, 2022

      Respiratory Syncytial Virus Infections Trial in United States (D46/NS2/N/?M2-2-HindIII, Placebo)

      Completed
      Has Results
      • Respiratory Syncytial Virus Infections
      • D46/NS2/N/ΔM2-2-HindIII
      • Placebo
      • Los Angeles, California
      • +9 more
      Jan 13, 2022

      Respiratory Syncytial Virus Infections Trial in Canada, Sweden, United States (RSVPreF3 OA investigational vaccine)

      Completed
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA investigational vaccine
      • Waterbury, Connecticut
      • +19 more
      Aug 5, 2022

      RSV Infection Trial in Baltimore (RSV 6120/?NS1, RSV 6120/F1/G2/?NS1, Placebo)

      Active, not recruiting
      • RSV Infection
      • RSV 6120/∆NS1
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins University Center for Immunization Research
      Feb 8, 2022

      Respiratory Syncytial Virus Infections Trial in Brisbane (CodaVax-RSV, Normal saline)

      Completed
      • Respiratory Syncytial Virus Infections
      • CodaVax-RSV
      • Normal saline
      • Brisbane, Queensland, Australia
        Nucleus Network/Q-Pharm
      Jun 8, 2021

      Respiratory Syncytial Virus Infections Trial in Belgium, United States (RSVPreF3 OA investigational vaccine (GSK3844766A))

      Completed
      Has Results
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA investigational vaccine (GSK3844766A)
      • Lenexa, Kansas
      • +9 more
      Jun 2, 2022

      Respiratory Syncytial Virus Infections Trial in Norfolk, Omaha, Cincinnati (Investigational RSV vaccine MV-012-968 (Dosage 1),

      Completed
      • Respiratory Syncytial Virus Infections
      • Investigational RSV vaccine MV-012-968 (Dosage 1)
      • +3 more
      • Norfolk, Nebraska
      • +2 more
      Jun 26, 2021

      Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, Placebo)

      Recruiting
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA investigational vaccine
      • Placebo
      • Daphne, Alabama
      • +56 more
      Jan 20, 2023

      Defining Burden of Disease of Respiratory Syncytial Virus in

      Active, not recruiting
      • RSV Infection
      • +2 more
      • No intervention
      • Turku, Finland
      • +4 more
      Jun 2, 2021

      Respiratory Syncytial Virus Infections Trial in United States (RSV cps2 Vaccine, Placebo Vaccine)

      Completed
      • Respiratory Syncytial Virus Infections
      • RSV cps2 Vaccine
      • Placebo Vaccine
      • La Jolla, California
      • +4 more
      Jul 19, 2021

      Respiratory Syncytial Virus Infections Trial in Belgium, Canada, United States (RSVPreF3 formulation 3, RSVPreF3 formulation 2,

      Active, not recruiting
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 formulation 3
      • +4 more
      • Miami, Florida
      • +7 more
      Nov 12, 2021

      Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)

      Active, not recruiting
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA investigational vaccine
      • FLU vaccine
      • Edegem, Belgium
      • +33 more
      Dec 7, 2022

      Respiratory Syncytial Virus Infections Trial in Melbourne (Respiratory Syncytial Vaccine, Placebo)

      Completed
      • Respiratory Syncytial Virus Infections
      • Respiratory Syncytial Vaccine
      • Placebo
      • Melbourne, Victoria, Australia
        Advanced Vaccine Laboratories Pty Ltd
      Apr 19, 2021

      Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA Investigational Vaccine)

      Not yet recruiting
      • Respiratory Syncytial Virus Infections
      • RSVPreF3 OA Investigational Vaccine
      • Phoenix, Arizona
      • +52 more
      Jun 16, 2023

      Influenza, Human, Respiratory Syncytial Virus Infections Trial in United States (Swab)

      Recruiting
      • Influenza, Human
      • Respiratory Syncytial Virus Infections
      • Swab
      • Birmingham, Alabama
      • +19 more
      Aug 16, 2022

      Bone Marrow Transplant Infection, Infection in Marrow Transplant Recipients, Respiratory Syncytial Virus Infections Trial in

      Completed
      Has Results
      • Bone Marrow Transplant Infection
      • +5 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Jan 21, 2021